The mechanism of action of quinocarmycin citrate (KW 2152) on mouse L1210 cells in vitro

Cancer Chemother Pharmacol. 1988;22(3):197-200. doi: 10.1007/BF00273410.

Abstract

The effects of the antitumor antibiotic, quinocarmycin citrate (KW 2152), on L1210 cells were studied in vitro. The cellular growth was completely inhibited at 10(-6) M KW 2152, and after 2 days no viable cell was seen. The incorporation of 3H-thymidine, 3H-uridine, or 3H-leucine into the acid-insoluble fraction was not affected at 10(-4) M for 1 h; however, when the cells were treated with 10(-6) M for 24 h, the radioactivity appearing in the acid-insoluble fraction was reduced to 20%, 30%, and 48%, respectively, of the control. The single strand scission of the DNA of L1210 cells was seen at 10(-7) M for 24 h, as revealed by an alkaline, sucrose density gradient. However, no damage to plasmid pBR322 was observed even at 10(-6) M KW 2152 for 24 h, as revealed by 0.8% agarose gel electrophoresis, indicating that some soluble factors of the cells might contribute to the damage to the DNA of L1210 cells. The processing of pre-rRNA of the cells was not inhibited at 10(-6) M of the drug for 24 h of incubation.

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacology*
  • Cell Division / drug effects
  • Centrifugation, Density Gradient
  • DNA, Neoplasm / drug effects
  • In Vitro Techniques
  • Isoquinolines / pharmacology
  • Leukemia L1210 / metabolism*
  • Mice
  • Neoplasm Proteins / biosynthesis
  • Plasmids / drug effects
  • RNA, Neoplasm / drug effects
  • RNA, Ribosomal / drug effects

Substances

  • Antibiotics, Antineoplastic
  • DNA, Neoplasm
  • Isoquinolines
  • Neoplasm Proteins
  • RNA, Neoplasm
  • RNA, Ribosomal
  • quinocarcin